Asako Nogami

1.2k total citations
48 papers, 685 citations indexed

About

Asako Nogami is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Asako Nogami has authored 48 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 16 papers in Hepatology and 11 papers in Surgery. Recurrent topics in Asako Nogami's work include Liver Disease Diagnosis and Treatment (32 papers), Liver Disease and Transplantation (12 papers) and Diet, Metabolism, and Disease (10 papers). Asako Nogami is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Liver Disease and Transplantation (12 papers) and Diet, Metabolism, and Disease (10 papers). Asako Nogami collaborates with scholars based in Japan, China and Singapore. Asako Nogami's co-authors include Masato Yoneda, Atsushi Nakajima, Takashi Kobayashi, Yasushi Honda, Michihiro Iwaki, Satoru Saito, Kento Imajo, Yuji Ogawa, Takaomi Kessoku and Kunihiro Hosono and has published in prestigious journals such as Circulation, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Asako Nogami

45 papers receiving 673 citations

Peers

Asako Nogami
G Bianchi Italy
Mi Hyun Bae South Korea
Dana Crişan Romania
Deniz Duman Türkiye
William Haufe United States
G Bianchi Italy
Asako Nogami
Citations per year, relative to Asako Nogami Asako Nogami (= 1×) peers G Bianchi

Countries citing papers authored by Asako Nogami

Since Specialization
Citations

This map shows the geographic impact of Asako Nogami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asako Nogami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asako Nogami more than expected).

Fields of papers citing papers by Asako Nogami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asako Nogami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asako Nogami. The network helps show where Asako Nogami may publish in the future.

Co-authorship network of co-authors of Asako Nogami

This figure shows the co-authorship network connecting the top 25 collaborators of Asako Nogami. A scholar is included among the top collaborators of Asako Nogami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asako Nogami. Asako Nogami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwaki, Michihiro, Takashi Kobayashi, Naohiro Wada, et al.. (2025). Efficacy of Magnetic Resonance Elastography in Fontan‐Associated Liver Disease. JGH Open. 9(9). e70274–e70274. 1 indexed citations
2.
Tang, Nicole K. Y., Benjamin Koh, Robert Lim, et al.. (2025). Meta‐Analysis: Utilisation of Hepatocellular Carcinoma Surveillance. Alimentary Pharmacology & Therapeutics. 63(1). 8–16. 1 indexed citations
3.
Song, Sherlot Juan, Asako Nogami, Lilian Yan Liang, et al.. (2024). Performance of continuous controlled attenuation parameter and liver stiffness measurement by the novel SmartExam in metabolic dysfunction‐associated steatotic liver disease. Liver International. 44(5). 1167–1175. 7 indexed citations
4.
Koyama, Shingo, Asako Nogami, Masato Yoneda, et al.. (2024). Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis. Tomography. 10(4). 471–479. 1 indexed citations
5.
Iwaki, Michihiro, Masato Yoneda, Naohiro Wada, et al.. (2024). Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitis. Expert Opinion on Emerging Drugs. 29(2). 127–137. 1 indexed citations
6.
Kobayashi, Takashi, Michihiro Iwaki, Asako Nogami, et al.. (2023). Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review. Nutrients. 15(5). 1269–1269. 4 indexed citations
7.
Yoneda, Masato, Takashi Kobayashi, Michihiro Iwaki, et al.. (2023). Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care. Gut and Liver. 17(6). 843–852. 5 indexed citations
8.
Kobayashi, Takashi, Michihiro Iwaki, Asako Nogami, et al.. (2023). Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography. Journal of Gastroenterology. 59(1). 56–65. 9 indexed citations
9.
Nogami, Asako, Naohiro Wada, Michihiro Iwaki, et al.. (2023). Mortality associated with the development of acute liver failure after a single dose of nivolumab. Clinical Journal of Gastroenterology. 16(3). 464–469. 4 indexed citations
11.
Morozumi, Toshiya, Yuko Yamamoto, Takashi Kobayashi, et al.. (2023). Association between Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma and Periodontopathic Bacteria: A Cross-Sectional Pilot Study. Applied Sciences. 13(6). 3893–3893. 3 indexed citations
12.
Kobayashi, Takashi, Michihiro Iwaki, Asako Nogami, & Masato Yoneda. (2023). Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 24 indexed citations
13.
Yoneda, Masato, Takashi Kobayashi, Yasushi Honda, et al.. (2022). Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial. Hepatology Communications. 6(9). 2273–2285. 31 indexed citations
14.
Honda, Yasushi, Masato Yoneda, Takashi Kobayashi, et al.. (2022). Meta‐analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease. Hepatology Research. 53(3). 219–227. 1 indexed citations
15.
Iwaki, Michihiro, Takaomi Kessoku, Kosuke Tanaka, et al.. (2022). Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease. JGH Open. 6(10). 696–703. 5 indexed citations
16.
Nogami, Asako, Michihiro Iwaki, Takashi Kobayashi, et al.. (2022). Real‐world assessment of SmartExam, a novel FibroScan computational method: A retrospective single‐center cohort study. Journal of Gastroenterology and Hepatology. 38(2). 321–329. 7 indexed citations
17.
Iwaki, Michihiro, Takaomi Kessoku, Kosuke Tanaka, et al.. (2022). Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study. BMJ Open. 12(7). e060335–e060335. 2 indexed citations
18.
Yoneda, Masato, Yasushi Honda, Yuji Ogawa, et al.. (2021). Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial. BMJ Open Diabetes Research & Care. 9(1). e001990–e001990. 78 indexed citations
19.
Yoneda, Masato, Yasushi Honda, Asako Nogami, Kento Imajo, & Atsushi Nakajima. (2020). Advances in ultrasound elastography for nonalcoholic fatty liver disease. Journal of Medical Ultrasonics. 47(4). 521–533. 22 indexed citations
20.
Kuwahara, Taishi, et al.. (2005). 心房細動患者における肺静脈隔離後に起こる急速及び不規則頻脈(偽心房租動)の評価. Circulation. 69. 227. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026